NDC 35781-0500 - WPR Plus
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 35781-0500
- Package NDCs from labels
- 35781-0500-3, 35781-0500-1, 35781-0500-9
- Manufacturer
- International Brand Management, LLC | Gensco Laboratories, LLC
- Effective date
- 2018-07-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| WPR Plus - International Brand Management, LLC | Gensco Laboratories, LLC | International Brand Management, LLC | Gensco Laboratories, LLC | 2018-07-17 | HUMAN PRESCRIPTION DRUG LABEL |
| WPR Plus - International Brand Management, LLC | International Brand Management, LLC | 2018-07-17 | HUMAN OTC DRUG LABEL |
| Lidocaine Hydrochloride - Gensco Laboratories, LLC | Gensco Laboratories, LLC | 2015-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 35781-0500-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d18c-f424-e053-dadaa90a57ce | LDO Plus (Lidocaine HCl USP) 4% |
| 35781-0500-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d18c-f424-e053-dadaa90a57ce | LDO Plus (Lidocaine HCl USP) 4% |
| 35781-0500-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d18c-f424-e053-dadaa90a57ce | LDO Plus (Lidocaine HCl USP) 4% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 35781-0500-3 | WPR Plus | 30 g in 1 TUBE | 30 g | 40 mg in 1g | 2 | |
| 35781-0500-1 | Lidocaine Hydrochloride | 15 g in 1 TUBE | GEL | 15 | 1 | |
| 35781-0500-1 | Lidocaine Hydrochloride | 1 in 1 CARTON | GEL | 1 | 1 | |
| 35781-0500-3 | WPR Plus | 30 g in 1 TUBE | 30 g | 40 mg in 1g | 1 | |
| 35781-0500-3 | Lidocaine Hydrochloride | 1 in 1 CARTON | GEL | 1 | 1 | |
| 35781-0500-3 | Lidocaine Hydrochloride | 30 g in 1 TUBE | GEL | 30 | 1 | |
| 35781-0500-9 | Lidocaine Hydrochloride | 1 in 1 CARTON | GEL | 1 | 1 | |
| 35781-0500-9 | Lidocaine Hydrochloride | 90 g in 1 TUBE | GEL | 90 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 35781-0500 | WPR PLUS () KIT [INTERNATIONAL BRAND MANAGEMENT, LLC] | 2 | Unmatched | 20180801_9d830535-2202-482d-9d1a-bccd7bbba855.zip |
| 35781-0500 | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | 6 package rows | 20151028_88dbd438-02c0-481a-bdb7-8b3f3c41fd46.zip |
| 35781-0500 | WPR PLUS () KIT [INTERNATIONAL BRAND MANAGEMENT, LLC] | 1 | Unmatched | 20180717_793d6fad-31a7-4b28-8395-73825bc18508.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 35781-0500-3 | ML - Milliliter | 35781-0500 | e34c830a-ebae-4476-af71-631a4ac662bc | 1 | 2015-11-12 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LIDOCAINE | ACTIVE INGREDIENT | 98PI200987 | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| FILIPENDULA ULMARIA FLOWER | INACTIVE INGREDIENT | 06L18L32G6 | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| POLYETHYLENE GLYCOL 3350 | INACTIVE INGREDIENT | G2M7P15E5P | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| QUERCUS ALBA WOOD | INACTIVE INGREDIENT | XR6BC2ZUAM | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| ZINC ACETATE | INACTIVE INGREDIENT | FM5526K07A | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | B697894SGQ PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R 936JST6JCN |
| Anubis Barcelona | PROPANEDIOL, GLYCERIN, MAGNESIUM ASCORBYL PHOSPHATE | ANUBIS COSMETICS SL | eb53cba1-0509-43bc-e053-2995a90a5e09 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R 230OU9XXE4 |
| Anubis Barcelona | FERULIC ACID, VITAMIN C, DMAE | ANUBIS COSMETICS SL | eaf0770c-795d-0232-e053-2a95a90ae0b5 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Regul OIl | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ARCTIUM MAJUS ROOT EXTRACT | ANUBIS COSMETICS SL | eb905bd0-c600-b8b2-e053-2995a90ad259 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT | ANUBIS COSMETICS SL | eb7c418b-8bee-26a3-e053-2a95a90a4e96 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | PDC6A3C0OX 059QF0KO0R |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | 059QF0KO0R |
| U ICE COLD | MENTHOL | UNIVERSAL DISTRIBUTION CENTER LLC | 752ef0cd-f12a-3b9e-e053-2991aa0abeb1 | 2023-09-01 | Warnings | L7T10EIP3A |
| LM Plus Relief | LIDOCAINE AND MENTHOL | ARI BRANDS, LLC | e9b52074-b4ca-43e9-9f2e-2afcdb5efdc7 | 2023-09-01 | Warnings, Adverse reactions | 98PI200987 L7T10EIP3A |
| LIDOCAINE AND PRILOCAINE | LIDOCAINE AND PRILOCAINE | A-S Medication Solutions | a4c310f5-e83e-4e40-a73d-818da5f49fec | 2023-08-17 | Warnings, Adverse reactions | 98PI200987 |
| Lidocaine and Prilocaine | LIDOCAINE AND PRILOCAINE | Alembic Pharmaceuticals Inc. | 7851790a-f2f3-4d65-9785-f77feafa8d93 | 2023-08-07 | Warnings, Adverse reactions | 98PI200987 |
| Lidocaine | LIDOCAINE | Septodont, Inc. | 82a4c16f-d47e-479f-8f85-7d1be6fc2318 | 2023-07-07 | Warnings, Adverse reactions | 98PI200987 |
| Mentholatum | METHYL SALICYLATE, DL-MENTHOL | Lydia Co., Ltd. | e9db590f-b19a-3fe8-e053-2995a90a4e74 | 2023-07-06 | Warnings | L7T10EIP3A LAV5U5022Y |
| AMULDY SPORTS gel | MENTHOL, METHYL SALICYLATE, CAMPHOR, SALICYLIC ACID | Lydia Co., Ltd. | a3fecbe6-4150-5d1e-e053-2995a90a974b | 2023-07-06 | Warnings | L7T10EIP3A LAV5U5022Y |
| SODIUM PHENYLACETATE AND SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | MAIA PHARMACEUTICALS, INC | 3529be10-0004-4628-9ca1-67a8acd86b51 | 2023-07-05 | Warnings, Adverse reactions | OJ245FE5EU |
| ANTIPHLAMINE | L-MENTHOL, L-CAMPHOR, METHYL SALICYLATE | Lydia Co., Ltd. | d4944ee3-23a3-f0b8-e053-2995a90a6ef1 | 2023-07-05 | Warnings | LAV5U5022Y |
| Hot Pap Cataplasma | METHYL SALICYLATE, VANILLYL NONYLAMIDE | Lydia Co., Ltd. | 85360782-69cc-ba9e-e053-2a91aa0a5431 | 2023-07-05 | Warnings | LAV5U5022Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.